Robert Wang is a highly experienced biostatistician with a career spanning over two decades in various prestigious organizations. Currently, Robert serves as the Director of Biostatistics at Amarin Corporation since April 2018. Prior roles include Consultant Biostatistician positions at Pfizer, Johnson & Johnson, Novartis, and Purdue Pharma L.P., alongside senior biostatistician roles at Serionix, Inc., Biogen, and PAREXEL. Robert began the professional journey at the Canadian Cardiac Centre and progressed through Health Canada after earning a Ph.D. in Statistics and a Master's degree in Statistics from the University of Toronto, alongside a Master of Engineering from the Beijing Institute of Technology and a Bachelor of Engineering from Shanghai Jiao Tong University.
This person is not in any teams
This person is not in any offices